Obesidade e Nutrición
Obesidade e Nutrición
![Foto de Obesidade e Nutrición](/img/grupo.png)
![Foto de Hospital Universitario Puerta de Hierro](/img/noimage_org.png)
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (5)
2013
-
Pegvisomant and cabergoline combination therapy in acromegaly
Pituitary, Vol. 16, Núm. 1, pp. 101-108
2009
-
Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: Its efficacy in relation to gender and previous radio therapy
European Journal of Endocrinology, Vol. 160, Núm. 4, pp. 535-542
2008
-
Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population
Clinical Endocrinology, Vol. 68, Núm. 6, pp. 942-950
2006
-
Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial
Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326
2003
-
Preoperative lanreotide treatment for GH-secreting pituitary adenomas: Effect on tumour volume and predictive factors of significant tumour shrinkage
Clinical Endocrinology, Vol. 58, Núm. 4, pp. 471-481